{"id":494773,"date":"2021-05-18T07:03:43","date_gmt":"2021-05-18T11:03:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/"},"modified":"2021-05-18T07:03:43","modified_gmt":"2021-05-18T11:03:43","slug":"alx-oncology-announces-upcoming-virtual-investor-conference-participation","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/","title":{"rendered":"ALX Oncology Announces Upcoming Virtual Investor Conference Participation"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BURLINGAME, Calif., May  18, 2021  (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc., (\u201cALX Oncology\u201d) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced that Jaume Pons, Ph.D., Founder, President and Chief Executive Officer and other senior executives, will participate in two upcoming virtual investor conferences.<\/p>\n<p align=\"justify\">\n        <strong>UBS 2021 Global Healthcare Virtual Conference<\/strong><br \/>\n        <br \/>Format: Podium presentation <br \/>Date: Monday, May 24<br \/>Time: 4:00 PM Eastern Time<br \/>Webcast link: Available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BMzJnpC4YleAlFcn07ZyW8P1k3ftzJOs_v6O36iKDCjNViSJQktJ4s_wrotttfNWbL0aUulzIb11Cg2WXZ5hqaZGTpTIOrpjANkDsV2wAj2jQvg8gkyCBYLoWnAXDrrK\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a><\/p>\n<p align=\"justify\">\n        <strong>Jefferies 2021 Virtual Healthcare Conference<\/strong><br \/>\n        <br \/>Format: Fireside chat with analyst, Michael Yee<br \/>Date: Wednesday, June 2<br \/>Time: 1:30 PM Eastern Time<br \/>Webcast link: Available <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xdVXJ3UZCuJxGQM-zKO9carPAq3kdoTPuq9EdANXepSmUpO55IzkXIIbq3pmwE_OrW4TOHN_EiWVS-ETUlFILzPOUZcaCP4v22Qa_xcP6W2PQpBlJNgzBL22XBe7uvpLbVzQOn7VCtV0w5u8mw8o-es7R4o970vA21LKTKiwr9qOuqUaO1pOjg1Ic3NjRD9M\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a><\/p>\n<p align=\"justify\">A live webcast of the UBS podium presentation and Jefferies fireside chat can be accessed by visiting the Investors section of ALX Oncology\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=03U8r6O8Si6G3qFX6NEUhbMPW8O7hLRZtXXZOU-7pUEIUFZ_xzxmTiNzyJGBHyjFu8fKhkrvQk0hA_ggfAuJ7lPH_nsb5sYFur6OsmJcMm8=\" rel=\"nofollow noopener\" target=\"_blank\">www.alxoncology.com<\/a> and selecting <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EmG8a_ZEi4P_YpwYLvA3wOcShm9Z84rr44WPy0eySjs8NJORi4MUo5HOweaxMUVUe4UnrubwjE4-G1Znq_2O7QFcXa5E6hOih-ixpAZWWGPR1B7e3xDjt9H-d8u_UdxB\" rel=\"nofollow noopener\" target=\"_blank\">Events<\/a> under the News and Events tab. A replay of the webcasts will be archived for up to 90 days following the presentation dates.<\/p>\n<p>\n        <strong>About ALX Oncology<\/strong>\n      <\/p>\n<p align=\"justify\">ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology\u2019s lead product candidate, ALX148, is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. ALX148 has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents. ALX Oncology intends to continue clinical development of ALX148 for the treatment of a range of solid tumor indications as well as MDS and AML. For more information, please visit ALX Oncology\u2019s website at www.alxoncology.com.<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzNzg4NiM0MTg3OTQzIzIxOTI4NjM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/c9786fd3-d096-4f83-b107-38166012b067\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Investor Contact:\r\n\r\nPeter Garcia\r\nChief Financial Officer, ALX Oncology\r\n(650) 466-7125 Ext. 113\r\npeter@alxoncology.com\r\n\r\nArgot Partners\r\n(212)-600-1902\r\nalxoncology@argotpartners.com\r\n\r\nMedia Contact:\r\n\r\nKaren Sharma\r\nMacDougall\r\n(781) 235-3060\r\nalx@macbiocom.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BURLINGAME, Calif., May 18, 2021 (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc., (\u201cALX Oncology\u201d) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced that Jaume Pons, Ph.D., Founder, President and Chief Executive Officer and other senior executives, will participate in two upcoming virtual investor conferences. UBS 2021 Global Healthcare Virtual Conference Format: Podium presentation Date: Monday, May 24Time: 4:00 PM Eastern TimeWebcast link: Available here Jefferies 2021 Virtual Healthcare Conference Format: Fireside chat with analyst, Michael YeeDate: Wednesday, June 2Time: 1:30 PM Eastern TimeWebcast link: Available here A live webcast of the UBS podium presentation and Jefferies fireside chat can be accessed by visiting the Investors section of ALX Oncology\u2019s website at www.alxoncology.com &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ALX Oncology Announces Upcoming Virtual Investor Conference Participation&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-494773","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ALX Oncology Announces Upcoming Virtual Investor Conference Participation - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ALX Oncology Announces Upcoming Virtual Investor Conference Participation - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BURLINGAME, Calif., May 18, 2021 (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc., (\u201cALX Oncology\u201d) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced that Jaume Pons, Ph.D., Founder, President and Chief Executive Officer and other senior executives, will participate in two upcoming virtual investor conferences. UBS 2021 Global Healthcare Virtual Conference Format: Podium presentation Date: Monday, May 24Time: 4:00 PM Eastern TimeWebcast link: Available here Jefferies 2021 Virtual Healthcare Conference Format: Fireside chat with analyst, Michael YeeDate: Wednesday, June 2Time: 1:30 PM Eastern TimeWebcast link: Available here A live webcast of the UBS podium presentation and Jefferies fireside chat can be accessed by visiting the Investors section of ALX Oncology\u2019s website at www.alxoncology.com &hellip; Continue reading &quot;ALX Oncology Announces Upcoming Virtual Investor Conference Participation&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-18T11:03:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzNzg4NiM0MTg3OTQzIzIxOTI4NjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ALX Oncology Announces Upcoming Virtual Investor Conference Participation\",\"datePublished\":\"2021-05-18T11:03:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\\\/\"},\"wordCount\":274,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIzNzg4NiM0MTg3OTQzIzIxOTI4NjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\\\/\",\"name\":\"ALX Oncology Announces Upcoming Virtual Investor Conference Participation - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIzNzg4NiM0MTg3OTQzIzIxOTI4NjM=\",\"datePublished\":\"2021-05-18T11:03:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIzNzg4NiM0MTg3OTQzIzIxOTI4NjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIzNzg4NiM0MTg3OTQzIzIxOTI4NjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ALX Oncology Announces Upcoming Virtual Investor Conference Participation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ALX Oncology Announces Upcoming Virtual Investor Conference Participation - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/","og_locale":"en_US","og_type":"article","og_title":"ALX Oncology Announces Upcoming Virtual Investor Conference Participation - Market Newsdesk","og_description":"BURLINGAME, Calif., May 18, 2021 (GLOBE NEWSWIRE) &#8212; ALX Oncology Holdings Inc., (\u201cALX Oncology\u201d) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced that Jaume Pons, Ph.D., Founder, President and Chief Executive Officer and other senior executives, will participate in two upcoming virtual investor conferences. UBS 2021 Global Healthcare Virtual Conference Format: Podium presentation Date: Monday, May 24Time: 4:00 PM Eastern TimeWebcast link: Available here Jefferies 2021 Virtual Healthcare Conference Format: Fireside chat with analyst, Michael YeeDate: Wednesday, June 2Time: 1:30 PM Eastern TimeWebcast link: Available here A live webcast of the UBS podium presentation and Jefferies fireside chat can be accessed by visiting the Investors section of ALX Oncology\u2019s website at www.alxoncology.com &hellip; Continue reading \"ALX Oncology Announces Upcoming Virtual Investor Conference Participation\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-18T11:03:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzNzg4NiM0MTg3OTQzIzIxOTI4NjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ALX Oncology Announces Upcoming Virtual Investor Conference Participation","datePublished":"2021-05-18T11:03:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/"},"wordCount":274,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzNzg4NiM0MTg3OTQzIzIxOTI4NjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/","name":"ALX Oncology Announces Upcoming Virtual Investor Conference Participation - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzNzg4NiM0MTg3OTQzIzIxOTI4NjM=","datePublished":"2021-05-18T11:03:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzNzg4NiM0MTg3OTQzIzIxOTI4NjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIzNzg4NiM0MTg3OTQzIzIxOTI4NjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alx-oncology-announces-upcoming-virtual-investor-conference-participation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ALX Oncology Announces Upcoming Virtual Investor Conference Participation"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/494773","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=494773"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/494773\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=494773"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=494773"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=494773"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}